ICON PLC (ICLR : NASDAQ)
Common Stock
$173.90
USD
+10.00 (6.10%)
Last updated: 2026-09-24
Follow ICLR
ICLR
ICON PLC
WealthAwesomePerformance
1 Day
+6.10%
1 Week
+2.49%
1 Month
+2.95%
YTD
+21.38%
Key Statistics
Market Cap
$13.42B
52W High
$203.91
52W Low
$66.57
P/E Ratio
248.43
50 Day MA
$167.28
200 Day MA
$146.93
Beta
1.20
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/24/2026 | $163.79 | $175.00 | $163.79 | $173.90 | $173.90 | 1,619,312 |
| 9/23/2026 | $167.77 | $169.28 | $163.41 | $163.90 | $163.90 | 1,062,913 |
| 9/22/2026 | $170.55 | $172.04 | $167.11 | $167.11 | $167.11 | 1,055,029 |
| 9/21/2026 | $164.61 | $169.95 | $163.16 | $169.55 | $169.55 | 1,031,665 |
| 9/18/2026 | $169.50 | $169.50 | $162.59 | $164.11 | $164.11 | 1,122,600 |
| 9/17/2026 | $175.01 | $177.50 | $169.44 | $169.68 | $169.68 | 1,172,030 |
| 9/16/2026 | $173.51 | $175.59 | $172.09 | $173.94 | $173.94 | 818,586 |
| 9/15/2026 | $168.02 | $172.94 | $167.72 | $172.45 | $172.45 | 862,417 |
| 9/14/2026 | $171.51 | $173.40 | $167.79 | $168.93 | $168.93 | 1,325,066 |
| 9/11/2026 | $165.68 | $175.63 | $165.68 | $169.31 | $169.31 | 1,710,005 |
Analyst Price Targets
Based on 17 analysts covering ICLR · as of Sep 21, 2026
Wall Street analysts forecast ICLR stock price to rise 6.5% over the next 12 months.
Consensus
Buy4.29 / 5.00
Avg. Target
US$185.25
+6.5% Upside
Previously US$185.56 on Sep 17, 2026
Current Price
US$173.90
Last close
Analyst Breakdown (17 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ICLR's historical volatility
30-Day Vol
38.9%
Annualized
90-Day Vol
43.7%
Annualized
Trend (90d)
+0.5%
Annualized drift
90d Mean
US$174.19
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$174.00 | US$152.15 – US$198.97 |
| 60 trading days | US$174.09 | US$144.01 – US$210.45 |
| 90 trading days | US$174.19 | US$138.07 – US$219.74 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About ICON PLC
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers testing services comprising bioanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, medical imaging, real world intelligence, site and patient, and strategic solutions. Additionally, it provides therapeutics for cardiovascular, central nervous system, endocrine and metabolic disorders, hepatology, infectious diseases, internal medicine immunology, and oncology. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Financials
- Revenue (TTM)
- $8.29B
- EBITDA
- $523.48M
- Profit Margin
- 0.33%
- ROE (TTM)
- 0.29%
- EPS (Diluted)
- 0.70
- Book Value
- 121.55
Classification
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About ICLR.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| RPGL | Republic Power Group Limited Class A Ordinary Shares | $14.69 | +1363.23% |
| KITT | Nauticus Robotics Inc. | $2.93 | +459.21% |
| ZWZZT | NASDAQ TEST STOCK | $24.50 | +144.51% |
| SRZN | Surrozen Inc | $33.68 | +108.42% |
| GLND | Greenland Energy Company Common Stock | $5.35 | +83.85% |
| PMAX | Powell Max Limited Class A Ordinary Shares | $1.65 | +80.62% |
| STAK | STAK Inc. Ordinary Shares | $1.44 | +53.19% |
| PFSA | Profusa, Inc. Common Stock | $3.03 | +47.80% |
ICLR.US news timeline
1 article covering ICLR.US, most recent first
Latest